Disseminated tumor cells and enhanced level of some cytokines in bone marrow and peripheral blood of breast cancer patients as predictive factors of tumor progression
Background: In recent years, the presence of disseminated tumor cells (DTC) in bone marrow (BM) of patients with breast cancer (BC) is considered as an important clinical feature of the distribution process. However, relapse often occurs in spite of the negative results of the bone marrow cytology....
Збережено в:
| Дата: | 2013 |
|---|---|
| Автори: | , , , , , , |
| Формат: | Стаття |
| Мова: | English |
| Опубліковано: |
Інститут експериментальної патології, онкології і радіобіології ім. Р.Є. Кавецького НАН України
2013
|
| Назва видання: | Experimental Oncology |
| Теми: | |
| Онлайн доступ: | http://dspace.nbuv.gov.ua/handle/123456789/145264 |
| Теги: |
Додати тег
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|
| Назва журналу: | Digital Library of Periodicals of National Academy of Sciences of Ukraine |
| Цитувати: | Disseminated tumor cells and enhanced level of some cytokines in bone marrow and peripheral blood of breast cancer patients as predictive factors of tumor progression / N. Semesiuk, A. Zhylchuk, N. Bezdenezhnykh, A. Lykhova, A. Vorontsova, V. Zhylchuk, Yu. Kudryavets // Experimental Oncology. — 2013. — Т. 35, № 4. — С. 295-302. — Бібліогр.: 62 назв. — англ. |
Репозитарії
Digital Library of Periodicals of National Academy of Sciences of Ukraine| id |
irk-123456789-145264 |
|---|---|
| record_format |
dspace |
| spelling |
irk-123456789-1452642019-01-21T01:23:22Z Disseminated tumor cells and enhanced level of some cytokines in bone marrow and peripheral blood of breast cancer patients as predictive factors of tumor progression Semesiuk, N. Zhylchuk, A. Bezdenezhnykh, N. Lykhova, A. Vorontsova, A. Zhylchuk, V. Kudryavets, Y. Special issue on breast cancer Background: In recent years, the presence of disseminated tumor cells (DTC) in bone marrow (BM) of patients with breast cancer (BC) is considered as an important clinical feature of the distribution process. However, relapse often occurs in spite of the negative results of the bone marrow cytology. This suggests the need to find additional signs of the possibility for predict the recurrence. Aim: to detect DTC in BM and determinate cytokine status of peripheral blood (PB) and BM of primary BC patients for prognosis of tumor recurrence. Patients and methods: 72 BC patients with histologically proven diagnosis were enrolled into study. 31 patients with progression of disease and 41 patients with clinical stabilization (conditional remission) were included to “progression” and “remission” group respectively. This division of BC patients was conditional and was made during the 3 years study. The presence of DTC in BM was detected by immunocytochemical analysis. Plasma levels of TNF-α, M-CSF, IFN-α were defined by bioassay tests. Plasma levels of IL-6, TGF-β1 and VEGF were determined by ELISA. BM and PB BC patients were obtained before treatment. Results: In our study DTC in samples of BM were detected in 50% BC patients of progression group. It was found that most significant addition markers of tumor progression with presence of DTC in BM are the levels of cytokines such as TNF in BM and PB, CSF-1 and IL-6 in PB and endogenous IFN in BM and PB of BC patients. In patients of disease “progression” group the levels of TNF in BM were increased by 45.8% (p < 0.01), the levels of CSF-1 and IL-6 in PB were increased more than by 70–80% (p < 0.05). Conclusion: Comprehensive detection DTC in BM and identification the level of TNF, IFN, CSF-1, IL-6 in PB and BM of BC patients could be one of the ways for prognosis the metastatic process and correction antitumor individualized therapy. 2013 Article Disseminated tumor cells and enhanced level of some cytokines in bone marrow and peripheral blood of breast cancer patients as predictive factors of tumor progression / N. Semesiuk, A. Zhylchuk, N. Bezdenezhnykh, A. Lykhova, A. Vorontsova, V. Zhylchuk, Yu. Kudryavets // Experimental Oncology. — 2013. — Т. 35, № 4. — С. 295-302. — Бібліогр.: 62 назв. — англ. 1812-9269 http://dspace.nbuv.gov.ua/handle/123456789/145264 en Experimental Oncology Інститут експериментальної патології, онкології і радіобіології ім. Р.Є. Кавецького НАН України |
| institution |
Digital Library of Periodicals of National Academy of Sciences of Ukraine |
| collection |
DSpace DC |
| language |
English |
| topic |
Special issue on breast cancer Special issue on breast cancer |
| spellingShingle |
Special issue on breast cancer Special issue on breast cancer Semesiuk, N. Zhylchuk, A. Bezdenezhnykh, N. Lykhova, A. Vorontsova, A. Zhylchuk, V. Kudryavets, Y. Disseminated tumor cells and enhanced level of some cytokines in bone marrow and peripheral blood of breast cancer patients as predictive factors of tumor progression Experimental Oncology |
| description |
Background: In recent years, the presence of disseminated tumor cells (DTC) in bone marrow (BM) of patients with breast cancer (BC) is considered as an important clinical feature of the distribution process. However, relapse often occurs in spite of the negative results of the bone marrow cytology. This suggests the need to find additional signs of the possibility for predict the recurrence. Aim: to detect DTC in BM and determinate cytokine status of peripheral blood (PB) and BM of primary BC patients for prognosis of tumor recurrence. Patients and methods: 72 BC patients with histologically proven diagnosis were enrolled into study. 31 patients with progression of disease and 41 patients with clinical stabilization (conditional remission) were included to “progression” and “remission” group respectively. This division of BC patients was conditional and was made during the 3 years study. The presence of DTC in BM was detected by immunocytochemical analysis. Plasma levels of TNF-α, M-CSF, IFN-α were defined by bioassay tests. Plasma levels of IL-6, TGF-β1 and VEGF were determined by ELISA. BM and PB BC patients were obtained before treatment. Results: In our study DTC in samples of BM were detected in 50% BC patients of progression group. It was found that most significant addition markers of tumor progression with presence of DTC in BM are the levels of cytokines such as TNF in BM and PB, CSF-1 and IL-6 in PB and endogenous IFN in BM and PB of BC patients. In patients of disease “progression” group the levels of TNF in BM were increased by 45.8% (p < 0.01), the levels of CSF-1 and IL-6 in PB were increased more than by 70–80% (p < 0.05). Conclusion: Comprehensive detection DTC in BM and identification the level of TNF, IFN, CSF-1, IL-6 in PB and BM of BC patients could be one of the ways for prognosis the metastatic process and correction antitumor individualized therapy. |
| format |
Article |
| author |
Semesiuk, N. Zhylchuk, A. Bezdenezhnykh, N. Lykhova, A. Vorontsova, A. Zhylchuk, V. Kudryavets, Y. |
| author_facet |
Semesiuk, N. Zhylchuk, A. Bezdenezhnykh, N. Lykhova, A. Vorontsova, A. Zhylchuk, V. Kudryavets, Y. |
| author_sort |
Semesiuk, N. |
| title |
Disseminated tumor cells and enhanced level of some cytokines in bone marrow and peripheral blood of breast cancer patients as predictive factors of tumor progression |
| title_short |
Disseminated tumor cells and enhanced level of some cytokines in bone marrow and peripheral blood of breast cancer patients as predictive factors of tumor progression |
| title_full |
Disseminated tumor cells and enhanced level of some cytokines in bone marrow and peripheral blood of breast cancer patients as predictive factors of tumor progression |
| title_fullStr |
Disseminated tumor cells and enhanced level of some cytokines in bone marrow and peripheral blood of breast cancer patients as predictive factors of tumor progression |
| title_full_unstemmed |
Disseminated tumor cells and enhanced level of some cytokines in bone marrow and peripheral blood of breast cancer patients as predictive factors of tumor progression |
| title_sort |
disseminated tumor cells and enhanced level of some cytokines in bone marrow and peripheral blood of breast cancer patients as predictive factors of tumor progression |
| publisher |
Інститут експериментальної патології, онкології і радіобіології ім. Р.Є. Кавецького НАН України |
| publishDate |
2013 |
| topic_facet |
Special issue on breast cancer |
| url |
http://dspace.nbuv.gov.ua/handle/123456789/145264 |
| citation_txt |
Disseminated tumor cells and enhanced level of some cytokines in bone marrow and peripheral blood of breast cancer patients as predictive factors of tumor progression / N. Semesiuk, A. Zhylchuk, N. Bezdenezhnykh, A. Lykhova, A. Vorontsova, V. Zhylchuk, Yu. Kudryavets // Experimental Oncology. — 2013. — Т. 35, № 4. — С. 295-302. — Бібліогр.: 62 назв. — англ. |
| series |
Experimental Oncology |
| work_keys_str_mv |
AT semesiukn disseminatedtumorcellsandenhancedlevelofsomecytokinesinbonemarrowandperipheralbloodofbreastcancerpatientsaspredictivefactorsoftumorprogression AT zhylchuka disseminatedtumorcellsandenhancedlevelofsomecytokinesinbonemarrowandperipheralbloodofbreastcancerpatientsaspredictivefactorsoftumorprogression AT bezdenezhnykhn disseminatedtumorcellsandenhancedlevelofsomecytokinesinbonemarrowandperipheralbloodofbreastcancerpatientsaspredictivefactorsoftumorprogression AT lykhovaa disseminatedtumorcellsandenhancedlevelofsomecytokinesinbonemarrowandperipheralbloodofbreastcancerpatientsaspredictivefactorsoftumorprogression AT vorontsovaa disseminatedtumorcellsandenhancedlevelofsomecytokinesinbonemarrowandperipheralbloodofbreastcancerpatientsaspredictivefactorsoftumorprogression AT zhylchukv disseminatedtumorcellsandenhancedlevelofsomecytokinesinbonemarrowandperipheralbloodofbreastcancerpatientsaspredictivefactorsoftumorprogression AT kudryavetsy disseminatedtumorcellsandenhancedlevelofsomecytokinesinbonemarrowandperipheralbloodofbreastcancerpatientsaspredictivefactorsoftumorprogression |
| first_indexed |
2023-05-20T17:21:40Z |
| last_indexed |
2023-05-20T17:21:40Z |
| _version_ |
1796153124457545728 |